Friday - February 20, 2026
Senate Special Committee on Aging Sets Feb. 26 Hearing on How FDA Bureaucracy Stifles Innovation
February 20, 2026
WASHINGTON, Feb. 20 -- The Senate Special Committee on Aging issued the following information for a hearing entitled "From Regulator to Roadblock: How FDA Bureaucracy Stifles Innovation" at 9:30 a.m. on Feb. 26, 2026, at 216 Hart Senate Office Building:

Witnesses

* Annie Kennedy, Chief Mission Officer, EveryLife Foundation for Rare Diseases, Washington, DC

* Dr. Jeremy Schmahmann MD, Director, Massachusetts General Hospital Ataxia Center, Boston, . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products